OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach
Xiangyu Li, Ko Eun Shong, Woonghee Kim, et al.
EBioMedicine (2022) Vol. 78, pp. 103963-103963
Open Access | Times Cited: 22

Showing 22 citing articles:

Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation
Han Jin, Cheng Zhang, Martin Zwahlen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40

A systematic review of computational approaches to understand cancer biology for informed drug repurposing
Faheem Ahmed, Anupama Samantasinghar, Afaque Manzoor Soomro, et al.
Journal of Biomedical Informatics (2023) Vol. 142, pp. 104373-104373
Open Access | Times Cited: 34

NetSDR: Drug repurposing for cancers based on subtype-specific network modularization and perturbation analysis
Bin Yang, Wanshi Li, Zhen Xu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167688-167688
Closed Access

Osalmid sensitizes clear cell Renal Cell Carcinoma to navitoclax through a STAT3/BCL-XL pathway
Yizheng Xue, Tianyi Chen, Z. Ma, et al.
Cancer Letters (2025) Vol. 613, pp. 217514-217514
Closed Access

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients
Abdulahad Bayraktar, Xiangyu Li, Woonghee Kim, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12

Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma
Occam Kelly Graves, Woonghee Kim, Mehmet Özcan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114486-114486
Open Access | Times Cited: 11

Single‐cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment
Bo Guan, Ming O. Li, Di Cui, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 4

Novel drug targets and molecular mechanisms for sarcopenia based on systems biology
Atakan Burak Ceyhan, Mehmet Özcan, Woonghee Kim, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116920-116920
Open Access | Times Cited: 4

Design and evaluation of novel inhibitors for the treatment of clear cell renal cell carcinoma
Younos Bouzian, Mohamed El Hafi, Negar Parvizi, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107597-107597
Closed Access | Times Cited: 3

Xanthotoxol suppresses non-small cell lung cancer progression and might improve patients’ prognosis
Xian Lin, Jingfeng Liu, Yujiao Zou, et al.
Phytomedicine (2022) Vol. 105, pp. 154364-154364
Closed Access | Times Cited: 15

Non-canonical NLRC4 inflammasomes in astrocytes contribute to glioma malignancy
JeongMin Sim, Ju Won Ahn, JeongMan Park, et al.
Inflammation Research (2023) Vol. 72, Iss. 4, pp. 813-827
Closed Access | Times Cited: 8

Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks
Shimei Qin, Li Wan, Hongzheng Yu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2244-2244
Open Access | Times Cited: 7

Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy
Xinmeng Liao, Mehmet Özcan, Mengnan Shi, et al.
Bioinformatics (2023) Vol. 39, Iss. 11
Open Access | Times Cited: 4

Comprehensive analysis of a tryptophan metabolism-related model in the prognostic prediction and immune status for clear cell renal carcinoma
Qinfan Yao, Xiuyuan Zhang, Yucheng Wang, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1

Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach
Ali Kaynar, Mehmet Özcan, Xiangyu Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7868-7868
Open Access | Times Cited: 1

Novel Inhibitors Targeting BUB1B for the Treatment of Clear Cell Renal Cell Carcinoma
Younos Bouzian, Mohamed El Hafi, Negar Parvizi, et al.
(2024)
Closed Access

Drug Repurposing for COVID-19 by Constructing a Comorbidity Network with Central Nervous System Disorders
Jing Qian, Bin Yang, Shuo Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8917-8917
Open Access

Long-read Spatial Transcriptomic Profiling of Patient-derived ccRCC Tumoroids Reveals Heterogeneity in Isoform and Gene Expression
Mustafa Elshani, Noor Hisham Abdullah, Ying Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Drug Repurposing Patent Applications July–September 2024
Hermann AM Mucke
Assay and Drug Development Technologies (2024)
Closed Access

The Human Pathology Atlas for deciphering the prognostic features of human cancers
Meng Yuan, Cheng Zhang, Kalle von Feilitzen, et al.
EBioMedicine (2024) Vol. 111, pp. 105495-105495
Open Access

Impact of statin on renal cell carcinoma patients undergoing nephrectomy. Does it affect cancer progression and improves survival? A Systematic Review and Meta-Analysis
Ghazian Adli, Niwanda Yogiswara, Ida Bagus Gde Tirta Yoga Yatindra, et al.
Archivio Italiano di Urologia e Andrologia (2023) Vol. 95, Iss. 3
Open Access

Page 1

Scroll to top